Psychostimulant Abuse - Novel Treatment Approaches - 1

This study has been completed.

First Received: September 20, 1999 Last Updated: June 23, 2005 History of Changes

Sponsor:	National Institute on Drug Abuse (NIDA)
Collaborator:	Mclean Hospital
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000325

Purpose

To determine if acute assessments of profasi and factrel affect plasma cocaine levels and cocaine-induced behavioral changes in men.

Condition	Intervention	Phase
Cocaine-Related Disorders	Behavioral: Gonadorelin	Phase I

Study Type:	Interventional
Study Design:	Treatment
Official Title:	Psychostimulant Abuse - Novel Treatment Approaches

Resource links provided by NLM:

Drug Information available for: Gonadorelin

Further study details as provided by National Institute on Drug Abuse (NIDA):

Estimated Enrollment:	0
Estimated Study Completion Date:	December 2001

Eligibility

Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000325

Locations

United States, Massachusetts
McLean Hospital, Dept. of Psychiatry
Belmont, Massachusetts, United States, 2178

Sponsors and Collaborators

Mclean Hospital

Investigators

Principal Investigator:

Jack Mendelson, M.D.

Mclean Hospital

More Information

No publications provided

Study ID Numbers:	NIDA-10757-1, R01-10757-1
Study First Received:	September 20, 1999
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00000325 History of Changes
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

Cocaine-Related Disorders
Mental Disorders
Substance-Related Disorders
Disorders of Environmental Origin

ClinicalTrials.gov processed this record on November 27, 2009